These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 7517496)

  • 1. Antagonist-mediated down-regulation of 5-hydroxytryptamine type 2 receptor gene expression: modulation of transcription.
    Toth M; Shenk T
    Mol Pharmacol; 1994 Jun; 45(6):1095-100. PubMed ID: 7517496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-hydroxytryptamine1C receptor density and mRNA levels in choroid plexus epithelial cells after treatment with mianserin and (-)-1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane.
    Barker EL; Sanders-Bush E
    Mol Pharmacol; 1993 Oct; 44(4):725-30. PubMed ID: 8232222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonergic antagonists differentially inhibit spontaneous activity and decrease ligand binding capacity of the rat 5-hydroxytryptamine type 2C receptor in Sf9 cells.
    Labrecque J; Fargin A; Bouvier M; Chidiac P; Dennis M
    Mol Pharmacol; 1995 Jul; 48(1):150-9. PubMed ID: 7623769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of agonists, partial agonists, and antagonists on the regulation of 5-hydroxytryptamine2 receptors in P11 cells.
    Ferry RC; Unsworth CD; Molinoff PB
    Mol Pharmacol; 1993 May; 43(5):726-33. PubMed ID: 8388988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic antidepressant exposure enhances 5-hydroxytryptamine7 receptor-mediated cyclic adenosine monophosphate accumulation in rat frontocortical astrocytes.
    Shimizu M; Nishida A; Zensho H; Yamawaki S
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1551-8. PubMed ID: 8968382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desensitization and down-regulation of 5-HT2 receptors in P11 cells.
    Ivins KJ; Molinoff PB
    J Pharmacol Exp Ther; 1991 Oct; 259(1):423-9. PubMed ID: 1656028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of rat 5-hydroxytryptamine type 2 receptor gene activity: identification of cis elements that mediate basal and 5-hydroxytryptamine-dependent gene activation.
    Du YL; Wilcox BD; Jeffrey JJ
    Mol Pharmacol; 1995 May; 47(5):915-22. PubMed ID: 7746279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation by 5-HT1A receptors of the 5-HT2 receptor-mediated tachykinin-induced contraction of the rat trachea in vitro.
    Germonpré PR; Joos GF; Pauwels RA
    Br J Pharmacol; 1998 Apr; 123(8):1571-8. PubMed ID: 9605563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and characterization of the rat 5-hydroxytryptamine type 2 receptor promoter: constitutive and inducible activity in myometrial smooth muscle cells.
    Du YL; Wilcox BD; Teitler M; Jeffrey JJ
    Mol Pharmacol; 1994 Jun; 45(6):1125-31. PubMed ID: 8022406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of serotonin-2C receptor G-protein coupling by RNA editing.
    Burns CM; Chu H; Rueter SM; Hutchinson LK; Canton H; Sanders-Bush E; Emeson RB
    Nature; 1997 May; 387(6630):303-8. PubMed ID: 9153397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inverse agonist and neutral antagonist actions of antidepressants at recombinant and native 5-hydroxytryptamine2C receptors: differential modulation of cell surface expression and signal transduction.
    Chanrion B; Mannoury la Cour C; Gavarini S; Seimandi M; Vincent L; Pujol JF; Bockaert J; Marin P; Millan MJ
    Mol Pharmacol; 2008 Mar; 73(3):748-57. PubMed ID: 18083778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased agonist, but not antagonist, binding to the naturally occurring Thr92Lys variant of the h5-HT7(a) receptor.
    Brüss M; Kiel S; Bönisch H; Kostanian A; Göthert M
    Neurochem Int; 2005 Aug; 47(3):196-203. PubMed ID: 15896881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WAY-100635 antagonist-induced plasticity of 5-HT receptors: regulatory differences between a stable cell line and an in vivo native system.
    Khawaja XZ; Smith DL; Nawoschik SP; Zhang J; Dunlop J; Dilks DW; Olsen M; Schechter LE
    J Neurochem; 2006 Jul; 98(1):134-45. PubMed ID: 16805803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of antidepressants on intracellular Ca2+ mobilization in CHO cells transfected with the human 5-HT2C receptors.
    Akiyoshi J; Isogawa K; Yamada K; Nagayama H; Fujii I
    Biol Psychiatry; 1996 Jun; 39(12):1000-8. PubMed ID: 8780834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged exposure to agonist results in a reduction in the levels of the Gq/G11 alpha subunits in cultured vascular smooth muscle cells.
    Kai H; Fukui T; Lassègue B; Shah A; Minieri CA; Griendling KK
    Mol Pharmacol; 1996 Jan; 49(1):96-104. PubMed ID: 8569718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signaling pathways mediating induction of the early response genes prostaglandin G/H synthase-2 and egr-1 by serotonin via 5-HT2A receptors.
    Goppelt-Struebe M; Stroebel M
    J Cell Physiol; 1998 Jun; 175(3):341-7. PubMed ID: 9572479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ejaculatory response induced by a 5-HT2 receptor agonist m-CPP in rats: differential roles of 5-HT2 receptor subtypes.
    Yonezawa A; Yoshizumi M; Ebiko M; Ise SN; Watanabe C; Mizoguchi H; Kimura Y; Sakurada S
    Pharmacol Biochem Behav; 2008 Feb; 88(4):367-73. PubMed ID: 17936345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective and divergent regulation of cortical 5-HT(2A) receptors in rabbit.
    Aloyo VJ; Dave KD; Rahman T; Harvey JA
    J Pharmacol Exp Ther; 2001 Dec; 299(3):1066-72. PubMed ID: 11714896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidepressant-like behavioral effects mediated by 5-Hydroxytryptamine(2C) receptors.
    Cryan JF; Lucki I
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1120-6. PubMed ID: 11082448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mianserin-induced down-regulation of human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors stably expressed in the human neuroblastoma cell line SH-SY5Y.
    Newton RA; Elliott JM
    J Neurochem; 1997 Sep; 69(3):1031-8. PubMed ID: 9282925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.